Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study

Objectives. Melatonin is an essential neuroendocrine hormone that participates in the regulation of sleep rhythm and cognitive function. This study aimed to determine serum melatonin levels with mild cognitive impairment (MCI) in patients with type 2 diabetes (T2DM). Methods. A total of 247 T2DM pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Jichen Zhang, Jiancan Lu, Hongling Zhu, Xinglu Zhou, Xijuan Wei, Mingjun Gu
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2021/5566019
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566023917666304
author Jichen Zhang
Jiancan Lu
Hongling Zhu
Xinglu Zhou
Xijuan Wei
Mingjun Gu
author_facet Jichen Zhang
Jiancan Lu
Hongling Zhu
Xinglu Zhou
Xijuan Wei
Mingjun Gu
author_sort Jichen Zhang
collection DOAJ
description Objectives. Melatonin is an essential neuroendocrine hormone that participates in the regulation of sleep rhythm and cognitive function. This study aimed to determine serum melatonin levels with mild cognitive impairment (MCI) in patients with type 2 diabetes (T2DM). Methods. A total of 247 T2DM patients were recruited in this retrospective study and divided into 75 subjects with MCI and 172 with normal cognition. Cognitive function was evaluated by the Montreal Cognitive Assessment (MoCA). Their blood sample was examined for the level of melatonin and other biochemical parameters. Results. Melatonin concentration was decreased in MCI patients to non-MCI patients (P < 0.001). Melatonin level was negatively correlated with age (r = −0.202; P = 0.001), diabetes duration (r = −0.282; P < 0.001), serum HbA1c (r = −0.195; P = 0.002), hs-CRP (r = −0.324; P < 0.001), and TSH (r = −0.184; P = 0.004) levels and positively correlated with MoCA score, serum HDL-C (r = 0.145; P < 0.001), FT3 (r = 0.241; P < 0.001), and FT4 (r = 0.169; P = 0.008) levels. The multivariable analysis indicated that fewer years of formal education, longer diabetes duration, higher serum HbA1c, higher serum hs-CRP, and lower serum melatonin are the predisposing factors for MCI. Conclusion. Lower melatonin level was associated with cognitive impairment in patients with T2DM. Melatonin might serve as a potential protective molecule against cognitive dysfunction in T2DM.
format Article
id doaj-art-cccbb519ad014d759f32e5bd71b1f043
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-cccbb519ad014d759f32e5bd71b1f0432025-02-03T01:05:20ZengWileyInternational Journal of Endocrinology1687-83371687-83452021-01-01202110.1155/2021/55660195566019Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional StudyJichen Zhang0Jiancan Lu1Hongling Zhu2Xinglu Zhou3Xijuan Wei4Mingjun Gu5The Graduate School, Ningxia Medical University, Yinchuan, Ningxia 750005, ChinaDepartment of Endocrinology, Shanghai Pudong New District Gongli Hospital, Second Military Medical University, Shanghai 200135, ChinaDepartment of Endocrinology, Shanghai Pudong New District Gongli Hospital, Second Military Medical University, Shanghai 200135, ChinaDepartment of Endocrinology, Shanghai Pudong New District Gongli Hospital, Second Military Medical University, Shanghai 200135, ChinaDepartment of Endocrinology, Shanghai Pudong New District Gongli Hospital, Second Military Medical University, Shanghai 200135, ChinaDepartment of Endocrinology, Shanghai Pudong New District Gongli Hospital, Second Military Medical University, Shanghai 200135, ChinaObjectives. Melatonin is an essential neuroendocrine hormone that participates in the regulation of sleep rhythm and cognitive function. This study aimed to determine serum melatonin levels with mild cognitive impairment (MCI) in patients with type 2 diabetes (T2DM). Methods. A total of 247 T2DM patients were recruited in this retrospective study and divided into 75 subjects with MCI and 172 with normal cognition. Cognitive function was evaluated by the Montreal Cognitive Assessment (MoCA). Their blood sample was examined for the level of melatonin and other biochemical parameters. Results. Melatonin concentration was decreased in MCI patients to non-MCI patients (P < 0.001). Melatonin level was negatively correlated with age (r = −0.202; P = 0.001), diabetes duration (r = −0.282; P < 0.001), serum HbA1c (r = −0.195; P = 0.002), hs-CRP (r = −0.324; P < 0.001), and TSH (r = −0.184; P = 0.004) levels and positively correlated with MoCA score, serum HDL-C (r = 0.145; P < 0.001), FT3 (r = 0.241; P < 0.001), and FT4 (r = 0.169; P = 0.008) levels. The multivariable analysis indicated that fewer years of formal education, longer diabetes duration, higher serum HbA1c, higher serum hs-CRP, and lower serum melatonin are the predisposing factors for MCI. Conclusion. Lower melatonin level was associated with cognitive impairment in patients with T2DM. Melatonin might serve as a potential protective molecule against cognitive dysfunction in T2DM.http://dx.doi.org/10.1155/2021/5566019
spellingShingle Jichen Zhang
Jiancan Lu
Hongling Zhu
Xinglu Zhou
Xijuan Wei
Mingjun Gu
Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study
International Journal of Endocrinology
title Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study
title_full Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study
title_fullStr Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study
title_full_unstemmed Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study
title_short Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study
title_sort association of serum melatonin level with mild cognitive impairment in type 2 diabetic patients a cross sectional study
url http://dx.doi.org/10.1155/2021/5566019
work_keys_str_mv AT jichenzhang associationofserummelatoninlevelwithmildcognitiveimpairmentintype2diabeticpatientsacrosssectionalstudy
AT jiancanlu associationofserummelatoninlevelwithmildcognitiveimpairmentintype2diabeticpatientsacrosssectionalstudy
AT honglingzhu associationofserummelatoninlevelwithmildcognitiveimpairmentintype2diabeticpatientsacrosssectionalstudy
AT xingluzhou associationofserummelatoninlevelwithmildcognitiveimpairmentintype2diabeticpatientsacrosssectionalstudy
AT xijuanwei associationofserummelatoninlevelwithmildcognitiveimpairmentintype2diabeticpatientsacrosssectionalstudy
AT mingjungu associationofserummelatoninlevelwithmildcognitiveimpairmentintype2diabeticpatientsacrosssectionalstudy